A Review of the Smallpox Vaccine Adverse Events Active Surveillance System
In response to concern about smallpox possibly being used as a biological weapon, the President of the United States launched the National Smallpox Pre-Event Vaccination Program on 13 December 2002. Given safety concerns, identifying potentially serious adverse events (SAEs) was an essential tool of...
Saved in:
Published in | Clinical infectious diseases Vol. 46; no. Supplement-3; pp. S212 - S220 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The University of Chicago Press
15.03.2008
University of Chicago Press Oxford University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In response to concern about smallpox possibly being used as a biological weapon, the President of the United States launched the National Smallpox Pre-Event Vaccination Program on 13 December 2002. Given safety concerns, identifying potentially serious adverse events (SAEs) was an essential tool of the program. To monitor for SAEs, both enhanced passive surveillance and active surveillance systems were used. The enhanced passive system was built, in part, on the existing Vaccine Adverse Event Reporting System; the active system was implemented 24 January 2003. During January 2003–May 2005, the active system detected only 1 SAE in addition to those reported through the enhanced passive system. Furthermore, the active system was not universally used by states. With the enhancements to passive surveillance, the performance of enhanced passive surveillance was comparable to that of active surveillance. However, an active surveillance system may be important when there is no enhanced passive surveillance system available. |
---|---|
Bibliography: | ark:/67375/HXZ-2D49XSQD-D istex:DCBAA080CA528EED514155202A1E58581244759D ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 1058-4838 1537-6591 |
DOI: | 10.1086/524742 |